ActiveNCT05416996

Feasibility Study of Randomizing Patients to Telemedicine Shared Medical Appointments Versus Telemedicine Single Visits for Men With Prostate Cancer on Active Surveillance

Sponsor: Memorial Sloan Kettering Cancer Center

Trial Details

Condition	Prostate Cancer
Status	Active
Participants	88
Est. Completion	1 June 2026
Last Updated	21 July 2026

Primary Outcome

accrual number; patient satisfaction

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * A scheduled appointment for a subsequent Active Surveillance (AS) follow-up visit for management of localized prostate cancer * Biopsy Gleason score 3+3=6 (Grade Group 1) or biopsy Gleason score 3+4=7 (Grade Group 2) * Clinical T stage ≤T2B * Access to a device with Zoom * Ability to speak and understand English Exclusion Criteria: * Plan to undergo a prostate biopsy at this follow-up visit

Trial Sites

Countries

United States

View Registry Entry

Related Analysis

Telemedicine Group Visits vs Individual Consultations for Prostate Cancer Active Surveillance: Feasibility Trial Results Pending

Memorial Sloan Kettering researchers are comparing telemedicine group visits with individual consultations for men with low-risk prostate cancer on active surveillance. This feasibility study could reshape how we deliver routine cancer follow-up care.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service